Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,701,954 | 1,335,326 | 711,072 | 109,096 | 2,461,419 |
| Depreciation Amortization | 34,773 | 24,131 | 15,806 | 8,211 | 36,714 |
| Accounts receivable | -400 | 2,005 | 3,312 | -2,815 | N/A |
| Other Working Capital | 202,962 | 123,967 | 81,706 | 40,932 | 260,584 |
| Other Operating Activity | 95,340 | -16,473 | 148,212 | 315,680 | -1,091,478 |
| Operating Cash Flow | $2,034,629 | $1,468,956 | $960,108 | $471,104 | $1,667,239 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,182,246 | -1,377,085 | -574,620 | -99,290 | -1,721,291 |
| Purchase Of Investment | -1,795,438 | -1,174,521 | -783,196 | -767,077 | N/A |
| Sale Of Investment | 1,203,280 | 609,604 | 336,012 | 104,613 | N/A |
| Other Investing Activity | 15,084 | 15,084 | 15,084 | 0 | -432,334 |
| Investing Cash Flow | $-2,759,320 | $-1,926,918 | $-1,006,720 | $-761,754 | $-2,153,625 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 11,891,030 | 11,891,030 | 6,040,000 | 6,040,000 | N/A |
| Debt Repayment | -11,210,400 | -11,210,400 | -5,264,596 | -5,217,496 | N/A |
| Common Stock Issued | 1,976,183 | 1,945,857 | 1,953,327 | 31,024 | N/A |
| Dividend Paid | -1,122,930 | -815,362 | -597,956 | -303,163 | -893,360 |
| Other Financing Activity | -46,711 | -46,560 | -8,819 | -7,841 | -298,266 |
| Financing Cash Flow | $1,487,172 | $1,764,565 | $2,121,956 | $542,524 | $-1,191,626 |
| Beginning Cash Position | 246,199 | 246,199 | 246,199 | 246,199 | 1,924,211 |
| End Cash Position | 1,008,680 | 1,552,802 | 2,321,543 | 498,073 | 246,199 |
| Net Cash Flow | $762,481 | $1,306,603 | $2,075,344 | $251,874 | $-1,678,012 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,034,629 | 1,468,956 | 960,108 | 471,104 | 1,667,239 |
| Capital Expenditure | -2,182,246 | -1,377,085 | -574,620 | -99,290 | N/A |
| Free Cash Flow | -147,617 | 91,871 | 385,488 | 371,814 | 1,667,239 |